Is routine testing mandatory or voluntary?
Explore the source record for details and available documents.
Delivery of Health Care↗
Biomedical subjects
Publications and source records attributed to Mel Stevens.
Explore the source record for details and available documents.
The GPIIb/IIIa inhibitors are potent anti-platelet agents with proven benefits in the treatment of patients with acute coronary syndromes and/or undergoing PCI. Assessment of the balance of risk and benefit needs to be undertaken in each individual case Consideration needs to be given to the economic impact of using these expensive drugs. There is much research activity in this rapidly evolving field and clinical experience is continually growing.